share_log

Iridex Publishes Peer-Reviewed Study In Ophthalmology Therapy; Highlights Safety And Efficacy Of MicroPulse Transscleral Laser Therapy In Managing Both Primary And Secondary Glaucoma Over Five Years.

Iridex Publishes Peer-Reviewed Study In Ophthalmology Therapy; Highlights Safety And Efficacy Of MicroPulse Transscleral Laser Therapy In Managing Both Primary And Secondary Glaucoma Over Five Years.

艾里德克斯发布了经同行评审的研究,关于眼科医疗治疗;强调了微脉冲巩膜激光治疗在管理原发性和继发性青光眼方面的安全性和有效性,历时五年。
Benzinga ·  12/19 05:06

Iridex Publishes Peer-Reviewed Study In Ophthalmology Therapy; Highlights Safety And Efficacy Of MicroPulse Transscleral Laser Therapy In Managing Both Primary And Secondary Glaucoma Over Five Years.

Iridex发布了经过同行评审的眼科疗法研究;重点介绍了MicroPulse经巩膜激光疗法在五年内治疗原发性和继发性青光眼的安全性和有效性。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发